Published in

Bentham Science Publishers, Current Pharmaceutical Design, 26(27), p. 2925-2933, 2021

DOI: 10.2174/18734286mtexhnduh4

Bentham Science Publishers, Current Pharmaceutical Design, 26(27), p. 2925-2933, 2021

DOI: 10.2174/1381612826666201112142408

Links

Tools

Export citation

Search in Google Scholar

Traditional Chinese Medicine Network Pharmacology in Cardiovascular Precision Medicine

Journal article published in 2020 by Min Cao ORCID, Li Gao ORCID, Jia-Qi Li, Xue-Mei Qin ORCID, Jian-Song Fang ORCID
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Cardiovascular disease is a major disease affecting human health, and its pathogenesis is caused by many factors. Through the use of "omics" technology, precision medicine is playing an increasingly important role in the prevention and treatment of cardiovascular diseases. Dialectical treatment with traditional Chinese medicine (TCM will result in personalized treatment, which is consistent with precision medicine to a certain extent. However, due to the multitarget, multipath, and multistep characteristics of TCM, its mechanism of action is not easy to elucidate. Network pharmacology can be used to predict the mechanism, toxicity and metabolic characteristics of TCM. This review summarizes commonly used bioinformatics resources for cardiovascular diseases and TCM, as well as the opportunities and challenges of TCM in cardiovascular precision medicine, with special emphasis on network pharmacology methods.